Skip to main content
Independent science journalism
We do not sell or supply peptides
Peptide
Science
Daily
News
Research
Compounds
Trials
Regulatory
Safety
Trackers
Search
⌘K
Subscribe
News
Research
Compounds
Trials
Regulatory
Safety
Trackers
Theme
Subscribe to the newsletter
We do not sell or supply peptides.
Home
Trials
NCT06449625
Clinical Trials · NCT06449625
Semaglutide in Auto-HSCT
Not Yet Recruiting
Phase 2
Semaglutide
(Investigational)
Phase
Phase 2
Recruitment status
Not Yet Recruiting
Sponsor
Klaus Gottlob Müller
Enrollment
40
Start date
Aug 2024
Locations
See registry
Primary endpoint
gastrointestinal mucositis severity
View Semaglutide compound reference